List view / Grid view

Regs & Legs



Developing next generation non-replicative HSV-1 vectors for sustainable and more precise gene therapies

22 January 2024 | By Drug Target Review, sponsored by Bio Rad Technologies

Watch this webinar to learn how the challenges with using certain viral vectors in gene therapy has advanced the development of a new generation of precise vectors with sustainable effects. Our experts outline the limitations of existing vectors and how these can be overcome using modified recombinant non-replicative herpes simplex…